Long-Term Prospective Study of the Influence of Estrone Levels on Events in Postmenopausal Women with or at High Risk for Coronary Artery Disease. (4th June 2012)

• Record Type: Journal Article
• Authors: Mansur, Antonio de Padua; Silva, Tereza Cristina B. F.; Takada, Julio Yoshio; Avakian, Solange Desirée; Strunz, Célia Maria C.; César, Luiz Antonio Machado; Aldrighi, José Mendes; Ramires, José Antonio F.
• Other Names: Murakawa Y. Academic Editor.; Pitt B. Academic Editor.; Spaulding C. Academic Editor.
• Is Part Of: TheScientificWorldjournal. Volume 2012(2012)
• Publication Date: 2012-06-04
• Subjects: Science -- Periodicals; Technology -- Periodicals; Medicine -- Periodicals; 505
• DOI: 10.1100/2012/363595
• Languages: English
• ISSNs: 2356-6140

Abstract

Abstract : Background . The link between endogenous estrogen, coronary artery disease (CAD), and death in postmenopausal women is uncertain. We analyzed the association between death and blood levels of estrone in postmenopausal women with known coronary artery disease (CAD) or with a high-risk factor score for CAD. Methods . 251 postmenopausal women age 50–90 years not on estrogen therapy. Fasting blood for estrone and heart disease risk factors were collected at baseline. Women were grouped according to their estrone levels (<15 and ≥15 pg/mL). Fatal events were recorded after 5.8 ± 1.4 years of followup. Results . The Kaplan-Meier survival curve showed a significant trend (P = 0.039 ) of greater all-cause mortality in women with low estrone levels (<15 pg/mL). Cox multivariate regression analysis model adjusted for body mass index, diabetes, dyslipidemia, family history, and estrone showed estrone (OR = 0.45 ; P = 0.038 ) as the only independent variable for all-cause mortality. Multivariate regression model adjusted for age, body mass index, hypertension, diabetes, dyslipidemia, family history, and estrone showed that only age (OR = 1.06 ; P = 0.017 ) was an independent predictor of all-cause mortality. Conclusions . Postmenopausal women with known CAD or with a high-risk factor score for CAD and low estrone levels (<15 pg/mL) had increased all-cause mortality.